Health FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients 365daily.net March 10, 2026 Food and Drug Administration Commissioner Marty Makary said in September he was changing leucovorin’s label because it could help “hundreds of thousands” of children with the neurological condition. Continue Reading Previous: Banyon Spends Nearly $40M on Tampa Office ComplexNext: I worked a corporate job for 8.5 years. I quit over a text message. Related Stories Health FTC sues transgender care group, arguing it deceived parents and patients Nermeen Nabil June 17, 2026 Health RFK Jr. is popping up in battleground districts Nermeen Nabil June 16, 2026 Health RFK Jr.’s olive branch isn’t winning over his staffers Nermeen Nabil June 13, 2026